The management of haemoglobinopathies.
Davies
S C
SC
Wonke
B
B
D000293:Adolescent; D000755:Anemia, Sickle Cell / Q000150:complications / Q000235:genetics / Q000503:physiopathology / Q000628:therapy*; D016026:Bone Marrow Transplantation; D015913:Chelation Therapy; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D003676:Deferoxamine / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D005914:Globins / Q000235:genetics; D006130:Growth Disorders / Q000209:etiology; D015658:HIV Infections / Q000209:etiology; D006801:Humans; D007223:Infant; D007501:Iron; D008297:Male; D009422:Nervous System Diseases / Q000209:etiology; D011628:Puberty, Delayed / Q000209:etiology; D013156:Splenectomy; D013158:Splenic Diseases / Q000209:etiology; D013789:Thalassemia / Q000150:complications / Q000235:genetics / Q000503:physiopathology / Q000628:therapy*; D065227:Transfusion Reaction
D005914:Globins; D007501:Iron; D003676:Deferoxamine